Kanpiduo

Indapamide / Candesartan cilexetil, the active ingredient in Kanpiduo, is an Angiotensin II receptor blocker (ARB) and thiazide‑like diuretic combination presented as a tablet for oral use. It is indicated for the management of hypertension in adult patients, helping to lower elevated blood pressure and reduce cardiovascular risk.

GNH USA supplies Kanpiduo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution to meet the needs of healthcare providers.

Kanpiduo is used to treat hypertension, a condition characterized by elevated arterial pressure.

- Essential hypertension: lowers blood pressure in patients with primary hypertension. - Renovascular hypertension: improves blood pressure control in patients with renal artery stenosis. - Hypertension with fluid retention: provides combined antihypertensive and diuretic effect to manage blood pressure and reduce edema.

Kanpiduo may cause a range of adverse reactions. Most are mild and reversible, but serious events can occur.

Common Side Effects: - Dizziness: feeling light‑headed, especially after standing. - Headache: mild to moderate intensity. - Increased urination: due to the diuretic component. - Fatigue: general tiredness. - Electrolyte imbalance: such as low potassium.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Hyperkalemia: dangerously high potassium levels. - Renal impairment: reduced kidney function. - Angioedema: swelling of face, lips, or throat. - Pancreatitis: inflammation of the pancreas. - Blood dyscrasias: abnormal blood cell counts.

Before prescribing Kanpiduo, clinicians should consider several safety factors.

- Renal function: assess baseline creatinine and eGFR. - Electrolytes: monitor potassium and sodium regularly. - Pregnancy: avoid unless clearly needed; data are limited. - Elderly: start at lower dose and watch for orthostatic hypotension. - Concomitant potassium‑sparing agents: risk of hyperkalemia. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Kanpiduo can interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Potassium supplements or potassium‑sparing diuretics: risk of hyperkalemia. - ACE inhibitors or other ARBs: additive hypotensive effect. - Lithium: increased lithium concentrations.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive response. - Thiazide diuretics: additive electrolyte disturbances. - Beta‑blockers: may mask tachycardia from hypotension.